179 related articles for article (PubMed ID: 6327476)
1. Liver immunoreactive prolyl hydroxylase protein in human primary hepatocellular carcinoma.
Bolarin D; Andy JJ; Alabi ZO
Hepatogastroenterology; 1983 Dec; 30(6):230-2. PubMed ID: 6327476
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactive prolyl hydroxylase protein and galactosylhydroxylysyl glucosyltransferase activity in breast tissues and sera of patients with primary breast cancer.
Bolarin DM
Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):493-502. PubMed ID: 6304825
[TBL] [Abstract][Full Text] [Related]
3. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin.
Murawaki Y; Kusakabe Y; Hirayama C
Hepatology; 1991 Dec; 14(6):1167-73. PubMed ID: 1683640
[TBL] [Abstract][Full Text] [Related]
4. Elevation of liver-galactosylhydroxylysyl glucosyltransferase activity in human primary hepatocellular carcinoma.
Bolarin DM
Int J Biochem; 1983; 15(10):1291-3. PubMed ID: 6313446
[TBL] [Abstract][Full Text] [Related]
5. Hepatic prolyl hydroxylase activity in human liver disease.
McPhie JL
Hepatogastroenterology; 1980 Aug; 27(4):277-82. PubMed ID: 6259037
[TBL] [Abstract][Full Text] [Related]
6. Enzymes of collagen synthesis and type III procollagen amino-propeptide in serum from Nigerians with hepato-cellular carcinoma and other malignant diseases.
Bolarin DM; Savolainen ER; Kivirikko KI
Int J Cancer; 1982 Apr; 29(4):401-5. PubMed ID: 6282764
[TBL] [Abstract][Full Text] [Related]
7. Glutamate dehydrogenase activity related to histopathological grade of hepatocellular carcinoma in man.
Glazer RI; Vogel CL; Patel IR; Anthony PP
Cancer Res; 1974 Nov; 34(11):2975-8. PubMed ID: 4370643
[No Abstract] [Full Text] [Related]
8. Liver collagen glucosyltransferase in experimental primary liver carcinoma.
Bolarin DM
Acta Physiol Hung; 1991; 77(2):113-20. PubMed ID: 1833951
[TBL] [Abstract][Full Text] [Related]
9. Studies on serum immunoreactive prolyl 4-hydroxylase in liver diseases--its elevation both in hepatocellular damage and cholestatic diseases.
Nagai Y; Yoshiba M
Clin Chim Acta; 1988 Jun; 175(1):27-36. PubMed ID: 2844441
[TBL] [Abstract][Full Text] [Related]
10. Serum albumin and total globulin levels in common liver diseases in Accra (Ghana).
Fenuku RI; Foli AK
Trop Geogr Med; 1978 Mar; 30(1):87-90. PubMed ID: 209591
[TBL] [Abstract][Full Text] [Related]
11. Selectivity of serum immunoreactive prolyl 4-hydroxylase as a marker for hepatic necrosis.
Nagai Y; Kato M; Toda G
J Gastroenterol Hepatol; 1992; 7(3):253-6. PubMed ID: 1319223
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of type III procollagen peptide in sera of patients with liver cancer].
Yamauchi M; Nakayama H; Fukuzawa K; Nakajima H; Takahara M; Nakahara M; Kawase H; Watanabe Y; Kimura K; Kitahara T
Gan No Rinsho; 1984 Jun; 30(7):785-90. PubMed ID: 6086978
[TBL] [Abstract][Full Text] [Related]
13. Urokinase antigen in plasma of patients with liver cirrhosis and hepatoma.
Kirchheimer JC; Huber K; Polterauer P; Binder BR
Thromb Haemost; 1985 Oct; 54(3):617-8. PubMed ID: 3003953
[TBL] [Abstract][Full Text] [Related]
14. Hepatic collagen proline hydroxylase activity in alcoholic hepatitis: effect of d-penicillamine.
Mezey E; Potter JJ; Iber FL; Maddrey WC
J Lab Clin Med; 1979 Jan; 93(1):92-100. PubMed ID: 215682
[No Abstract] [Full Text] [Related]
15. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
[TBL] [Abstract][Full Text] [Related]
16. [The correlation of Child-Pugh score, PGA index and MELD score in the patient with liver cirrhosis and hepatocellular carcinoma according to the cause of alcohol and hepatitis B virus].
Mun BS; Ahn HS; Ahn DS; Lee SO
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):107-15. PubMed ID: 12824750
[TBL] [Abstract][Full Text] [Related]
17. Activities of serum enzymes in patients with viral hepatitis B, posthepatitic cirrhosis and hepatocellular carcinoma.
Zheng T; Ren ZY
Chin Med J (Engl); 1990 Sep; 103(9):729-34. PubMed ID: 2174763
[TBL] [Abstract][Full Text] [Related]
18. Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma.
Hsu PI; Chow NH; Lai KH; Yang HB; Chan SH; Lin XZ; Cheng JS; Huang JS; Ger LP; Huang SM; Yen MY; Yang YF
Anticancer Res; 1997; 17(4A):2803-9. PubMed ID: 9252719
[TBL] [Abstract][Full Text] [Related]
19. [Measurement of human serum and liver tissue immunoreactive gamma-glutamyl transpeptidase in patients with various liver diseases].
Yamada M
Hokkaido Igaku Zasshi; 1988 Jan; 63(1):44-55. PubMed ID: 2896151
[TBL] [Abstract][Full Text] [Related]
20. Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
Takahashi H; Saibara T; Iwamura S; Tomita A; Maeda T; Onishi S; Yamamoto Y; Enzan H
Hepatology; 1994 Jun; 19(6):1414-7. PubMed ID: 7514563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
